AQR Arbitrage’s Amgen AMGN Stock Holding History

AQR Arbitrage’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,314	Closed	-$523K	–	998
2020 Q4	$523K	Buy	+2,314	New	+$534K	0.02%	636

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AQR Arbitrage's AMGN Position: Q1 2021 in Review

AQR Arbitrage sold out of Amgen (AMGN) in Q1 2021, closing a stake of 2,314 shares — an estimated $523K sold.

AQR Arbitrage first reported a position in AMGN in Q4 2020 and held it in 1 quarter. The position peaked at $523K in Q4 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

AQR Arbitrage reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 2,314 Amgen shares in Q1 2021, an estimated $523K.
AQR Arbitrage first reported a position in Amgen in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's Amgen position peaked at $523K in Q4 2020.
2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.